Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric cancer research, revealing how the "second brain"—nerves in the digestive ...
A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ...
RICHMOND, Va. (WRIC) — A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancer’s origins within the body, as well as insights into new treatment ...
Please provide your email address to receive an email when new articles are posted on . The blood test reliably detected patients with stage I and II pancreatic ductal adenocarcinoma with 97% accuracy ...
Researchers have solved a mystery about the most important driver of cancer development - a mutant protein found in half of all cancers - and how it contributes to tumor growth. Researchers from WEHI ...
The genetic code of a rare form of kidney cancer, called reninoma, has been studied for the first time. In the new paper, published today (25th September) in Nature Communications, researchers at the ...
There is an unresolved debate about the extent to which the environment contributes to cancer risk. Although epidemiological studies suggest that environmental factors such as diet can certainly ...
Many people have loved ones who have been affected by cancer. There will be an estimated 1.9 million new cancer cases diagnosed in 2022, according to Cancer.org. While there is no definite cure, there ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
We can credit clinical trials for great improvements made in cancer care in recent years. Death rates for 11 of the 19 most common cancers in men and 14 of the 20 most common cancers in women ...
The recent approval of Lumakras (Amgen, AMG 510) by the US Food and Drug Administration as a treatment for non-small cell lung cancer is a breakthrough in cancer therapy. The drug acts as an ...